This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hossack J et al. (2008) A case of adult hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol 5: 344–348
Chang S et al. (2006) Hepatic visceral larva migrans of Toxocara canis: CT and sonographic findings. AJR Am J Roentgenol 187: W622–W629
Lim JH (2008) Toxocariasis of the liver: visceral larva migrans. Abdom Imaging 33: 151–156
Despommier D (2003) Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 16: 265–272
Sturchler D et al. (1989) Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol 83: 473–478
Akao N and Ohta N (2007) Toxocariasis in Japan. Parasitol Int 56: 87–93
Yoshikawa M (2007) Treatment of toxocariasis. In Treatment Manual for Parasitic Diseases -2007- (version 6.0), 69 (Eds Nawa Y et al.) Research Group on Chemotherapy of Tropical Diseases, Japan (http://www.med.miyazaki-u.ac.jp/parasitology/orphan/docDL/tebiki6-0.pdf) (Japanese)
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Yoshikawa, M. Duration of treatment with albendazole for hepatic toxocariasis. Nat Rev Gastroenterol Hepatol 6, E1–E2 (2009). https://doi.org/10.1038/ncpgasthep1367
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1367